Female sex-specific considerations to improve rigor and reproducibility in cardiovascular research
- 1 March 2023
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 324 (3) , H279-H287
Abstract
Cardiovascular disease is the leading cause of death in women. Despite recognition of sex-specific differences in cardiovascular health, females are underrepresented across all aspects of cardiovascular research, playing a key role in reducing rigor and reproducibility in cardiovascular research and contributing to these poorer health outcomes. Therefore, we propose a framework to capture factors associated with the female sex at the preclinical, recruitment, data collection, and data analysis stages. In preclinical cardiovascular research, female experimental models are commonly excluded despite similar variability in findings compared with males. To reduce this sex bias, the inclusion of female models and the incorporation of sex as a biological variable are critical to improve reproducibility and inform clinical research and care. Although funding agencies have mandated the inclusion of women in clinical trials, greater efforts are needed to achieve optimal participation-to-prevalence ratio to increase the generalizability of results to real-world settings. Female participants face more stringent exclusion criteria in research compared with males owing to sex-specific factors. However, their routine exclusion from cardiovascular research is not only unethical but limits generalizability and applicability to clinical practice. Identifying sex assigned at birth, collecting information on female sex-specific and -predominant factors associated with cardiovascular health and risk, and stratifying data by sex, including adverse events, are essential to ensure reproducibility and relevance of findings to target populations. Increasing female representation and the incorporation of female sex-specific cardiovascular risk factors in cardiovascular research will not only lead to enhanced rigor and reproducibility but improved cardiovascular health for all.Keywords
This publication has 96 references indexed in Scilit:
- Impact of Bleeding on Mortality After Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2011
- Sex bias in neuroscience and biomedical researchNeuroscience & Biobehavioral Reviews, 2011
- Males still dominate animal studiesNature, 2010
- Of Mice and Women: The Bias in Animal ModelsScience, 2010
- Status of Women in Cardiovascular Clinical TrialsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Major Femoral Bleeding Complications After Percutaneous Coronary InterventionJACC: Cardiovascular Interventions, 2008
- Incorporating a gender perspective into the development of clinical guidelines: a training course for guideline developersImplementation Science, 2007
- Comparison of patient recall of hormone therapy with physician recordsMenopause, 2007
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenNew England Journal of Medicine, 2005
- Age-associated changes in plasma testosterone levels in male mice and their relation to social dominance or subordinanceHormones and Behavior, 1981